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Abstract
Background: Expression quantitative trait loci (eQTL) analysis identifies
genetic markers associated with the expression of a gene. Most existing eQTL
analyses and methods investigate association in a single, readily available tis-
sue, such as blood. Joint analysis of eQTL in multiple tissues has the potential
to improve, and expand the scope of, single-tissue analyses. Large-scale col-
laborative efforts such as the Genotype-Tissue Expression (GTEx) program
are currently generating high quality data in a large number of tissues. How-
ever, computational constraints limit genome-wide multi-tissue eQTL analysis.
Results: We develop an integrative method under a hierarchical Bayesian
framework for eQTL analysis in a large number of tissues. The model fitting
procedure is highly scalable, and the computing time is a polynomial function
of the number of tissues. Multi-tissue eQTLs are identified through a local false
discovery rate approach, which rigorously controls the false discovery rate. Us-
ing simulation and GTEx real data studies, we show that the proposed method
has superior performance to existing methods in terms of computing time and
the power of eQTL discovery. Conclusions: We provide a scalable method for
eQTL analysis in a large number of tissues. The method enables the identifica-
tion of eQTL with different configurations and facilitates the characterization
of tissue specificity.
1 Background
Expression quantitative trait loci (eQTL) analyses identify single nucleotide polymor-
phisms (SNPs) that are associated with the expression level of a gene. A gene-SNP
pair such that the expression of the gene is associated with the value of the SNP is
referred to as an eQTL. One may view eQTL analyses as Genome-Wide Association
Studies (GWAS) with multiple molecular phenotypes. Identification of eQTLs is a
key step in investigating genetic regulatory pathways. To date, numerous eQTLs
have been discovered to be associated with human traits such as height and complex
diseases such as Alzheimer’s disease and diabetes [2, 12].
With few exceptions, existing eQTL studies have focused on a single tissue; in
human studies this tissue is usually blood. An important next step in exploring
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the genomic regulation of expression is to simultaneously study eQTLs in multiple
tissues. Multi-tissue eQTL analysis can strengthen the conclusions of single tissue
analyses by borrowing strength across tissues, and can help provide insight into the
genomic basis of differences between tissues, as well as the genetic mechanisms of
tissue-specific diseases.
Recently, the NIH Common Fund’s Genotype-Tissue Expression (GTEx) project
has undertaken a large-scale effort to collect and and analyze eQTL data in multi-
ple tissues on a growing set of human subjects, and there has been a concomitant
development of methods for the analysis of such data. Flutre et al. [8] developed a
Bayesian method to jointly analyze eQTLs in multiple tissues. The method relies on
a permutation test to evaluate significance levels. Li et al. [11] developed an empirical
Bayes approach called MT-eQTL (“MT” stands for multi-tissue). The method uses
an approximate expectation-maximization (EM) algorithm to fit the model, and con-
trols the false discovery rate (FDR) of eQTL detections by adaptively thresholding
local false discovery rates derived from the fitted model. Both [8] and [11] make use
of a binary configuration vector, with dimension equal to the number of available
tissues, to describe, for each gene-SNP pair, the presence or absence of association in
each tissue. Sul et al. [15] proposed a Meta-Tissue method to combine linear mixed
models with meta-analysis to detect eQTL in multiple tissues. The method analyzes
one gene-SNP pair at a time. Initial analyses and conclusions of the GTEx project are
described in [17]. As part of this work, the multi-tissue eQTL methods of [8] and [11]
were applied to 9 human tissues with sample size greater than 80, focusing on local
(cis) pairs for which the SNP is within one mega-base (Mb) of the transcription start
site (TSS) of the gene. The analysis found that most eQTLs are common across all
tissues, though the effect size may vary from tissue to tissue. In addition, there are
a small, but potentially interesting, set of eQTLs that are present only in a subset of
tissues, the most common cases being eQTLs that are present in only one tissue, or
present in all but one tissue.
As GTEx and related projects proceed, data are being collected from an increas-
ing number of subjects, and an increasing number of tissues. In the current GTEx
database (v6p), more than 20 tissues have a sample size greater than 150. Existing
eQTL analysis methods are limited in one way or another in performing simultaneous
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local eQTL analysis in a large number of tissues. On the one hand, methods like [8]
and [11] quickly become intractable as the total number of configurations grows expo-
nentially in the number of tissues. On the other hand, methods such as [15] need to
fit a model for each gene-SNP pair; the fitting time is impractical when the number
of gene-SNP pairs and the number of tissues are large.
In this paper, we develop an efficient computational tool, called HT-eQTL (“HT”
stands for high-tissue), for joint eQTL analysis. The method builds on the hierar-
chical Bayesian model developed in [11], but the estimation procedure is significantly
modified to address scaling issue associated with a large number of tissues. Rather
than fitting a full model, HT-eQTL fits models for all pairs of tissues in a parallel
fashion, and then synthesizes the resulting pairwise models into a higher order model
for all tissues. To do this, we exploit the marginal compatibility of the hierarchical
Bayesian model, which is not an obvious property and was proven in [11]. An im-
portant innovation is that we employ a multi-Probit model and thresholding to deal
with the exponentially growing configuration space. The resulting model and fitting
procedure can be efficiently applied to the simultaneous eQTL analysis of 20-25 tis-
sues. Empirical Bayesian methods for controlling false discovery rates in multiple
hypothesis testing are developed. We design testing procedures to detect different
families of eQTL configurations. We show that the eQTL detection power of HT-
eQTL is similar to that of MT-eQTL, and that both outperform the tissue-by-tissue
approach, in a simulation study with a moderate number of tissues. We also compare
HT-eQTL with the Meta-Tissue method in the analysis of the GTEx v6p data. This
analysis shows that the methods have largely concordant results, but that HT-eQTL
gains additional power by borrowing strength across tissues.
2 Methods
In this section we describe the HT-eQTL method, beginning with a review of the hi-
erarchical Bayesian model and the MT-eQTL method in [11], and then describing our
proposal on how to fit the Bayesian model in high-tissue settings. Next, we describe
a local false discovery rate based method for performing flexible eQTL inference. Fi-
nally, we discuss a marginal test and a marginal transformation to check and improve
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the goodness of fit of the model.
2.1 Review: Bayesian Hierarchical Modal and MT-eQTL
Procedure
Consider a study with n subjects and K tissues. From each subject we have genotype
data and measurements of gene expression in a subset of tissues. In many cases,
covariate correction will be performed prior to analysis of eQTLs. For k = 1, . . . , K,
let nk ≤ n denote the number of subjects contributing expression data from tissue k.
Let λ = (i, j) be the index of a gene-SNP pair consisting of gene i and SNP j, and let
Λ be the set of all local (cis) gene-SNP pairs. For λ = (i, j) ∈ Λ and k = 1, . . . , K,
let rλ(k) denote the sample correlation between the expression level of gene i and
the (covariate corrected) minor allele frequency of SNP j in tissue k, and ρλ(k) be
the corresponding population correlation. Define rλ = (rλ(1), . . . , rλ(K)) to be the
vector of sample correlations across tissues, and define the vector ρλ of population
correlations in the same fashion.
Let Zλ = h(rλ) · d1/2, where h(·) is the entrywise Fisher transformation, · is
the Hadamard product, and d is a K-vector whose kth component is the number of
samples in tissue k minus the number of covariates removed from tissue k minus 3.
With proper preprocessing of the gene expression data, the vector Zλ is approximately
multivariate normal [13] with mean µλ = h(ρλ) · d1/2 and marginal variance one.
In particular, if ρλ(k) = 0 then the kth component of Zλ has a standard normal
distribution, and can therefore be used as a z-statistic for testing ρλ(k) = 0 vs ρλ(k) 6=
0. Thus we refer to Zλ as a z-statistic vector.
The MT-eQTL model introduced in [11] is a Bayesian hierarchical model for the
random vector Zλ. The model can be expressed in the form of a mixture as
Zλ ∼
∑
γ∈{0,1}K
p(γ)NK ( µ · γ , ∆ + Σ · γγ′ ) . (1)
The mixture in (1) is taken over the set {0, 1}K of length K binary vectors. Each
vector γ ∈ {0, 1}K represents a particular configuration of eQTLs across the K avail-
able tissues: γk = 1 if the gene-SNP pair indexed by λ is an eQTL in tissue k, and
γk = 0 otherwise. We define Hamming class m (m = 0, · · · , K) as the set of all binary
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K-vectors having m ones, which correspond to all configurations in which there is an
eQTL in m tissues and no eQTL in K − m tissues. The first parameter p(·) is a
probability mass function on {0, 1}K with the interpretation that p(γ) is the prior
probability of the configuration γ. The K-vector µ characterizes the average true
effect size of eQTLs in each tissue. The K × K correlation matrix ∆ captures the
behavior of Zλ when no eQTLs are present (γ = 0): its diagonal entries are 1 due
to variance stabilization, and its off-diagonal entries reflect correlations arising from
subject overlap between tissues. The K×K covariance matrix Σ captures the covari-
ance structure arising from the underlying biology: its diagonal entries reflect tissue
specific variation in true effect sizes, and its off-diagonal entries reflect covariance of
true effect sizes between tissues due to tissue commonalities. Let θ = {p,µ,∆,Σ}
denote the set of unknown model parameters.
Under the model (1) the distribution of Zλ is a normal mixture with each compo-
nent corresponding to a specific eQTL configuration. In particular, if γ = 0 (λ is not
an eQTL in any tissue) then Zλ ∼ NK(0,∆); if γ = 1 (λ is an eQTL in all tissues)
then Zλ ∼ NK(µ,∆ + Σ). The true configuration vector for each gene-SNP pair λ
can be viewed as a latent variable. The main goal of a statistical analysis is to obtain
the posterior distribution of each latent variable, and to use it to make inferences
about eQTL configurations in multiple tissues.
In order to make inference about configuration vectors, we first estimate the model
parameters θ = {p,µ,∆,Σ}. In practice it is common to set the average effect size
vector µ to 0, as minor alleles are equally likely to be associated with high or low
expression, and we assume in what follows that µ = 0. The remaining parameters
can be estimated within a maximum pseudo-likelihood framework, where the pseudo-
likelihood is defined as the product of the likelihoods of all considered gene-SNP
pairs. We note that factorizing the likelihood in this way ignores dependence between
adjacent and nearby SNPs arising from linkage disequilibrium. However, our interest
is not in the joint behavior of the vectors Zλ but in their marginal behavior, which
is reflected in the mixture (1). In particular, the parameters in Model (1) determine,
and are determined by, the marginal distribution of the vectors Zλ, and do not depend
on joint distribution of the vectors Zλ.
A modified EM algorithm was devised in [11] to estimate the parameters from
6
the pseudo-likelihood. While the method scales linearly with sample size and the
number of gene-SNP pairs, its computational time increases exponentially with the
number of tissues K (see Figure 1). For genome-wide studies, it is infeasible to apply
the method to data with more than a few tissues. Moreover, the number of config-
urations grows exponentially with the number of tissues as well, making inference
about configurations difficult as well. Below we introduce a scalable procedure, the
HT-eQTL method, to address multi-tissue eQTL analysis in about 20 tissues.
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Figure 1: The model fitting times of MT-eQTL and HT-eQTL for a sequence of nested
models with dimensions 2 to 9 in the simulation study.The solid line with circles is
for MT-eQTL, and the dashed line with triangles is for HT-eQTL.
2.2 The HT-eQTL Method
The original MT-eQTL model has the desirable property of being marginally compat-
ible. Let the dimension of the MT-eQTL model be the number of available tissues.
Marginal compatibility means that: 1) the marginalization of a K-dimensional model
to a subset of L tissues has the same general form as the K-dimensional model; and
2) the corresponding parameters for the L-dimensional model are obtained in the
obvious way by restricting the parameters of the K-dimensional model to the subset
of L tissues.
Because of marginal compatibility, it is straightforward to obtain a sub-model
from a high dimensional model without refitting the MT-eQTL parameters. The
HT-eQTL method, which is discussed below, estimates the high dimensional model
from the collection of its one- and two-dimensional sub-models. Thus we address
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the computationally intractable problem of estimating a high dimensional model by
considering a manageable number of sub-problems that can be solved efficiently, and
in parallel.
In the MT-eQTL model, the covariance matrices ∆ and Σ reflect interactions
between pairs of tissues, while the probability mass function p(·) captures higher order
relationships between tissues. The HT-eQTL model is built from estimates of all one-
and two-dimensional sub-models, which can be computed in parallel. In particular,
we make use of a Multi-Probit model to approximate the K-th order probability mass
function p(·) from the probability mass functions of two-dimensional models. In what
follows we denote the estimated parameters of the two-dimensional model for tissue
pair (i, j) by
pij = (pij00, p
ij
01, p
ij
10, p
ij
11), ∆
ij =
 1 δij
δij 1
 , Σij =
σij11 σij12
σij21 σ
ij
22
 .
Assemble ∆: For each tissue pair (i, j) where 1 ≤ i < j ≤ K, the corresponding
off-diagonal value of ∆ is denoted by δij. An asymptotically consistent estimate of
δij is the off-diagonal value of ∆
ij, which is the null covariance matrix for the two-
dimensional model for tissue pair (i, j). Making this substitution for each i < j
and placing ones along the diagonal yields a symmetric matrix ∆ˆ0. If ∆ˆ0 is positive
definite, it is directly used as an estimate ∆ˆ of ∆. Otherwise (which never happened
in our numerical studies), one could replace the non-positive eigenvalues of ∆ˆ with
0.01 and rescale the matrix to have the diagonal entries equal to one.
Assemble Σ: To estimate the covariance matrix Σ = {σij}, we decompose it into the
diagonal values, which are tissue-specific variances, and the corresponding correlation
matrix. For each diagonal entry σkk (k = 1, · · · , K), there are K − 1 estimates,
namely σ1k22 , · · · , σ(k−1)k22 , σk(k+1)11 , · · · , σkK11 . In practice, the distribution of z-statistics
is usually heavy-tailed, inflating the pairwise estimates of the variance. As a remedy,
we propose to use the minimum of the K − 1 estimates as the estimate of σkk to
compensate the inflation effect. The induced correlation matrix from Σ is estimated
in the same way as ∆. In particular, we begin with a matrix having ones along
the diagonal, and off-diagonal entries σij12/
√
σij11σ
ij
22. After resetting any non-positive
eigenvalue to 0.01, we rescale the matrix to have diagonal values equal to 1, and
combine it with the variance estimates to obtain the estimate Σˆ.
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The Multi-Probit Model for p: Existing multi-tissue eQTL studies [11, 17] sup-
port several broad conclusions about eQTL configurations across tissues. Researchers
found that most gene-SNP pairs were not an eQTL in any tissue (Hamming class 0) or
were an eQTL in all tissues (Hamming class K). With larger sample sizes and a larger
number of tissues (thus providing increased power to detect cross-tissue sharing), we
expect these two Hamming classes to predominate.
In general, the probability mass functions obtained from two-dimensional models
will not determine a unique probability mass function on the full K-dimensional
model. Here we make use of a multi-Probit model through which we equate the values
of the estimated probability mass function with integrals of a multivariate normal
probability density. In particular, for each tissue pair (i, j), we select thresholds
τ ij1 , τ
ij
2 ∈ R and a correlation ωij ∈ (0, 1) so that if (Wi,Wj) are bivariate normal with
mean zero, variance one, and correlation ωij then
Pr
{
I(Wi ≥ τ ij1 ) = u and I(Wj ≥ τ ij2 ) = v
}
= pij(u, v)
for each u, v ∈ {0, 1}. Here I(A) is the indicator function of A, and pij(·) is the
estimated probability mass function for the pair (i, j).
Beginning with a symmetric matrix having diagonal values 1 and off-diagonal
values equal to ωij, we define a correlation matrix Ω following the procedure used to
define ∆ˆ. Let φK(·) be the probability density function of the correspondingK-variate
normal distribution NK(0,Ω). For each tissue j, we define an aggregate threshold τ j
to be the minimum of τ ij1 (i < j) and τ
ji
2 (j < i). Here we use the minimum because
pairwise models may occasionally overestimate the null prior probability pij(0, 0).
Subsequently, for each configuration γ ∈ {0, 1}K , we define the probability
p(γ) =
∫
I1
· · ·
∫
IK
φK(x)dx
where Ik is equal to (−∞, τ k] if γk = 0, and (τ k,∞), if γk = 1. Consequently, we
obtain the estimate of probability mass function p for the K-dimensional model.
Threshold p(·): In practice, many of the 2K possible configurations will have esti-
mated probabilities close to zero. In order to further reduce the number of configura-
tions, we set the threshold for the prior probabilities to be 10−5, and truncate those
values below the threshold to be zero. The remaining probabilities are rescaled to
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have total mass one. As a result, the total number of configurations with non-zero
probabilities is dramatically reduced to a manageable level for subsequent inferences.
2.3 Inferences
The first, and often primary, goal of eQTL analysis in multiple tissues is to detect
which gene-SNP pairs are an eQTL in some tissue. Subsequent testing may seek to
identify gene-SNP pairs that are an eQTL in a specific tissues, and pairs that are an
eQTL in some, but not all, tissues. As the model (1) is fit with large number of gene-
SNP pairs, we ignore the estimation error associated with the model parameters and
treat the estimated values as fixed and true for the purposes of subsequent inference.
The mixture model (1) may be expressed in an equivalent, hierarchical form, in
which for each gene-SNP pair λ, there is a latent random vector Γλ ∈ Γ indicating
whether or not that pair is an eQTL in each of the K tissues. The prior distribution of
Γλ is characterized by the probabilistic mass function p(·). In the hierarchical model,
given that Γλ = γ, the random z-statistic vector Zλ has distribution NK(0,∆ + Σ ·
γγ′). The posterior distribution of Γλ given the observed vector zλ can be used to
test eQTL configurations for the gene-SNP pair λ.
Detection of eQTLs with specified configurations can be formulated as a multiple
testing problem, and addressed through the use of local false discovery rates derived
from the posterior distribution of gene-SNP pairs. Suppose that we are interested in
identifying gene-SNP pairs with eQTL configurations in a set S ⊆ {0, 1}K . This can
be cast as a multiple testing problem
H0,λ : Γλ ∈ Sc versus H1,λ : Γλ ∈ S
where λ ∈ Λ. Rejecting the null hypothesis for a gene-SNP pair λ indicates that λ is
likely to have an eQTL configuration in S. There are several families S of particular
interest, corresponding to different configurations of interest:
• Testing for the presence of an eQTL in any tissue: S = {γ : γ 6= 0}
• Testing for presence of a tissue-specific eQTL, i.e., an eQTL in some, but not
all, tissues: S = {γ : γ 6= 0, γ 6= 1}
• Testing for presence of an eQTL in tissue k only: S = {γ : γk = 1}
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• Testing for presence of a common eQTL, i.e., an eQTL in all tissues: S = {1}.
To carry out multiple testing under the hierarchical Bayesian model, we make use
of the local false discovery rate (lfdr) for the set S, which is defined as the posterior
probability that the configuration Γ lies in Sc given the observed z-statistics vector
z. The local false discovery rate was introduced by [7] in the context of an empirical
Bayes analysis of differential expression in microarrays. Other applications can be
found in [5, 6, 14]. Formally, the lfdr for S ⊆ {0, 1}K is defined by
ηS(z) := Pr(Γ ∈ Sc | Z = z) =
∑
γ∈Sc p(γ)fγ(z)∑
γ∈{0,1}K p(γ)fγ(z)
, (2)
where fγ(z) is the pdf of NK(0,∆ + Σ · γγ′). Thus ηS(zλ) is the probability of the
null hypothesis given the z-statistic vector for the gene-SNP pair λ. Small values of
the lfdr provide evidence for the alternative hypothesis H1,γ. In order to control the
overall false discovery rate (FDR) for the multiple testing problem across all gene-SNP
pairs λ ∈ Λ we employ an adaptive thresholding procedure for local false discovery
rates [7, 11, 14, 16]. For a given set of configurations S, and a given false discovery
rate threshold α ∈ (0, 1), the procedure operates as follows.
• Calculate the lfdr ηS(zλ) for each λ ∈ Λ.
• Sort the lfdrs from smallest to largest as ηs(λ(1)) ≤ · · · ηs(λ(N)).
• Let N be the largest integer such that
1
N
N∑
i=1
ηs(λ(i)) < α.
• Reject hypotheses H0,λ(i) for i = 1, . . . , N .
It is shown in [11] that the adaptive procedure controls the FDR at level α under
very mild conditions. Consequently, we obtain a set of discoveries with FDR below
the nominal level α.
3 Results
In the first part of this section, we conduct a simulation study with 9 tissues. We
compare HT-eQTL with the MT-eQTL [11], Meta-Tissue [15] and tissue-by-tissue
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(TBT) [3, 4, 9, 10] methods on different eQTL detection problems. The Meta-Tissue
approach leverages the fixed effects and random effects method to address effect size
heterogeneity and detect eQTLs across multiple tissues. The TBT approach first
evaluates the significance of gene-SNP association in each tissue separately, and then
aggregates the information across tissues. We also compare HT-eQTL and MT-eQTL
in terms of the model fitting times and parameter estimation accuracy. Then we apply
the two scalable methods, HT-eQTL and Meta-Tissue, to the GTEx v6p data with
20 tissues.
3.1 Simulation
In the simulation study, we generate z-statistics directly from Model (1) with K =
9 tissues, using the MT-eQTL model parameters estimated from the GTEx pilot
data [11]. More specifically, for each gene-SNP pair, we first randomly generate a
length-K configuration vector according to the prior probability mass function p,
and then simulate a K-vector of effect sizes from the corresponding multivariate
Gaussian distribution. We simulate 105 gene-SNP pairs in total. The true eQTL
configurations for the simulated data are known and used to compare the efficacy of
different methods.
We first compare the computational costs of the MT-eQTL model fitting and
the HT-eQTL model fitting (without parallelization). We consider a sequence of
nested models with dimensions from 2 to 9. The model fitting times on the simulated
data are shown in Figure 1. We demonstrate that the model fitting time for the
MT-eQTL grows exponentially in the number of tissues, while it grows much slower
for the HT-eQTL. Namely, the HT-eQTL scales better than the MT-eQTL. This is
because the HT-eQTL model fitting only involves the fitting of all the 2-tissue MT-
eQTL models and a small overhead induced by assembling the pairwise parameters.
When the total number of gene-SNP pairs and the number of tissues are large, the
advantage of HT-eQTL is significant. Based on the timing results for MT-eQTL on
the 9-tissue GTEx pilot data in [11], we project its fitting time to be more than 30
CPU years on 20 tissues. As we describe later, fitting the HT-eQTL model on the
20-tissue GTEx v6p data only takes less than 3 CPU hours. We remark that the
straightforward parallelization of the 2-tissue MT-eQTL model fittings will further
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reduce the computational cost for HT-eQTL.
Now we compare the parameter estimation from MT-eQTL and HT-eQTL. We
particularly focus on the 9-tissue model. The HT-eQTL parameters are obtained by
fitting all 2-tissue MT-eQTL models and assembling the pairwise parameters. The
MT-eQTL parameters are obtained directly by fitting the 9-tissue MT-eQTL model.
Regarding the estimation of the correlation matrix ∆, the quartiles of the entry-wise
relative errors are (0.86%, 2.42%, 4.36%) and (0.81%, 2.00%, 2.72%) for HT-eQTL
and MT-eQTL, respectively. Regarding the estimation of the covariance matrix Σ,
the quartiles of the entry-wise relative errors are (1.13%, 2.41%, 3.25%) and (0.36%,
0.68%, 1.08%) for HT-eQTL and MT-eQTL, respectively. Namely, both methods
estimated the covariance matrices very accurately. For the probability mass vector p,
we calculated the Kullback-Liebler divergence of different estimates from the truth,
defined as DKL(p‖p̂) =
∑2K
i=1 pi log (pi/p̂i). The MT-eQTL estimate has a very small
divergence of 0.025 while the HT-eQTL estimate has a slightly larger divergence of
0.141. Overall, the HT-eQTL estimates are slightly less accurate than the MT-eQTL
estimates, which is expected because the HT-eQTL method has fewer degrees of
freedom than the MT-eQTL method. When there are abundant data relative to the
number of parameters, the more complicated MT-eQTL model will result in more
accurate estimation. Nevertheless, we emphasize that the HT-eQTL estimates are
sufficiently accurate for the eQTL detection purposes (see Figure 2).
Next, we compare the eQTL detection power of different methods. We particularly
focus on the detection of four types of eQTLs: (a) eQTLs in at least one tissue
(Any eQTL); (b) eQTLs in all tissues (Common eQTL); (c) eQTLs in at least one
tissue but not all tissues (Tissue-Specific eQTL); (d) eQTLs in a single tissue (Single-
Tissue eQTL). In addition to the MT-eQTL and HT-eQTL methods, we also consider
the Meta-Tissue and TBT approaches. In order to detect Any eQTL, we exploit
the random effects model in Meta-Tissue and a minP procedure in TBT, where the
minimum p value across tissues is used as the test statistics for each gene-SNP pair.
To detect Common eQTL, we use the fixed effects model in Meta-Tissue and a maxP
procedure in TBT, where the maximum p values across tissues are used. To detect
Tissue-Specific eQTL, we devise a diffP procedure for TBT, where the test statistics
for each gene-SNP pair is the difference between the maximum and the minimum
13
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Figure 2: The ROC curves of different methods for different eQTL detection problems
in the simulation study. (a) Any eQTL detection; (b) Common eQTL detection; (c)
Tissue-specific eQTL detection; (d) Single-tissue eQTL detection.
p values across tissues. A large value indicates the discrepancy between the two
extreme p values is large, and thus provides a strong evidence for the gene-SNP pair
to be a tissue-specific eQTL. Similarly, for Meta-Tissue, we exploit the difference of p
values from the fixed effects model and the random effects model as the test statistics.
Finally, for Single-Tissue eQTL detection, Meta-Tissue reduces to the TBT method.
We just use the p values in the primary tissue and ignore those in other tissues. For
the MT-eQTL and HT-eQTL methods, we adapt the lfdr test statistics in (2) to
different testing problems accordingly.
We evaluate the performance of different methods using the Receiver Operating
Characteristic (ROC) curves for different eQTL detection problems. The results are
shown in Figure 2. The oracle curves correspond to the lfdr approach based on the true
model with the true parameters. In all eQTL detection problems, the MT-eQTL and
HT-eQTL methods have comparable performance, very similar to the oracle results.
While we expect the MT-eQTL to perform similarly to the oracle procedure, it is
surprising that the HT-eQTL, only using information in tissue pairs, also provides
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comparable results to the oracle procedure. Both MT-eQTL and HT-eQTL clearly
outperform the Meta-Tissue and TBT approaches in all detection problems.
To sum up, the HT-eQTL method achieves high parameter estimation accuracy
and eQTL detection power at a low computational cost. For a large number of tissues,
it provides a preferable alternative to the MT-eQTL method.
3.2 GTEx v6p Data
The GTEx v6p data constitute the most recent freeze for official GTEx Consortium
publications, and can be accessed from the GTEx portal at http://www.gtexportal.
org/home/. We apply the HT-eQTL method to 20 tissues (selected by the GTEx
Analysis Working Group), including 2 brain tissues, 2 adipose tissues, and a hetero-
geneous set of 16 other tissues. We consider all 70, 724, 981 cis gene-SNP pairs where
the SNP is within 1Mb of the TSS of the gene.
To obtain model parameters using HT-eQTL, we first fit
(
20
2
)
= 190 2-tissue
models, and then assemble all the pairwise parameters following the procedure in
the method section. The probability mass vector p estimated from the Multi-Probit
model is summarized in Figure 3. We particularly focus on 377 configurations with
prior probabilities greater than 10−5. The prior probabilities are added up for con-
figurations in the same Hamming class, providing a general characterization of the
multi-tissue eQTL distribution. The parabolic shape estimated from the data is con-
cordant with previous results from the pilot study [17]. The global null configuration
(the binary 0 vector) has the largest probability of 0.9359, and the common eQTL
configuration (the binary 1 vector) has the second largest probability of 0.0396. Con-
figurations in Hamming class 1 (eQTL in only one tissue) and 19 (eQTL in all but
one tissues) have relatively large probabilities. All other configurations have much
lower probabilities.
Recall that Σ captures the covariance of effect sizes in different tissues when
eQTLs are present. We treat the correlation matrix induced from Σ as the distance
metric between tissues, and use the single linkage to conduct hierarchical clustering
for the 20 tissues. The dendrogram is shown in Figure 4. We demonstrate that
similar tissues, such as the two adipose tissues and the breast tissue, or the two brain
tissues, are grouped together. The whole blood is apparently different from all the
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Figure 3: The summary plot of the probability mass vector estimated from the HT-
eQTL method on the GTEx v6p 20-tissue data. The prior probabilities are added up
for configurations in the same Hamming class and then log-transformed.
other tissues. These findings are concordant with those in the pilot analysis [17].
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Figure 4: The clustering result of 20 tissues in the GTEx v6p data analysis. The
distance metric is the correlation of eQTL effect sizes between tissues, estimated
from the HT-eQTL method.
We also carry out testing of eQTL configurations (at a fixed the FDR level of 5%)
for the presence of an eQTL in any tissue, in all tissues, in at least one but not all
tissues, and in each individual tissue. The number of discoveries are shown in Table
1. As a comparison, we also apply the Meta-Tissue method [15] to the same data
set. In particular, we focus on the Any eQTL detection problem, using p values from
the random effects model in Meta-Tissue. We apply the Benjamini and Yekutieli
approach [1] to control the FDR at the level of 5%. As a result, we obtain over 6.36
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million cis pairs from the Meta-Tissue method. About 3.60 million of these pairs are
shared with the HT-eQTL method. We further investigate the unique discoveries of
each method. As shown in the left panel of Figure 5, the unique discoveries made by
HT-eQTL have very small p values from the Meta-Tissue method, indicating those
are likely to be “near” discoveries for the Meta-Tissue method as well. In the right
panel of Figure 5, however, the excessive unique discoveries made by Meta-Tissue have
highly enriched large lfdr values. This suggests the unique Meta-Tissue discoveries
may have inflated false discovery rate, potentially due to the inadequacy of the p-
value-based FDR control method for highly dependent tests.
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Figure 5: Histograms of the Meta-Tissue p values for the unique Any eQTL discoveries
made by HT-eQTL (left), and the HT-eQTL lfdr for the unique Any eQTL discoveries
made by Meta-Tissue (right).
4 Discussion
In this paper, we develop a new method, HT-eQTL, for joint analysis of eQTL in
a large number of tissues. The method builds upon the empirical Bayesian frame-
work proposed in [11], but is significantly improved in computation and inference to
accommodate a large number of tissues. The model fitting procedure only involves
the estimation of all 2-tissue models, and the obtained pairwise parameters are then
assembled to get the full model parameters. The detection of eQTLs with different
configurations is addressed by adaptively thresholding the corresponding local false
discovery rates, which efficiently borrow strength across tissues and control the nom-
inal FDR. Finally, the numerical studies demonstrate the efficacy of the proposed
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Table 1: The numbers of discoveries and the corresponding percentages of total cis
pairs for different eQTL detection problems. The FDR level is fixed at 5% for all
testing problems.
eQTL Configuration Number (×1E6) Percentage (%)
eQTL in Any Tissue 4.088 5.78
eQTL in All Tissues 0.708 1.00
Tissue-Specific eQTL 0.239 0.34
Adipose Subcutaneous 3.640 5.15
Adipose Visceral Omentum 3.536 5.00
Adrenal Gland 3.302 4.67
Artery Tibial 3.671 5.19
Brain Cerebellum 3.329 4.71
Brain Cortex 3.120 4.41
Breast Mammary Tissue 3.507 4.96
Colon Transverse 3.515 4.97
Esophagus Mucosa 3.716 5.25
Heart Left Ventricle 3.433 4.85
Liver 1.727 2.44
Lung 3.576 5.06
Muscle Skeletal 3.581 5.06
Nerve Tibial 3.712 5.25
Ovary 2.999 4.24
Pancreas 3.479 4.92
Prostate 3.021 4.27
Skin Sun Exposed Lower Leg 3.717 5.26
Thyroid 3.758 5.31
Whole Blood 3.147 4.45
method. In the GTEx v6p data analysis, we apply HT-eQTL to 20 tissues. The
estimated prior probabilities of eQTL configurations show that most eQTLs are com-
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mon across all tissues or present in a single tissue. The estimated effect sizes provide
additional insights into the tissue similarity and clustering. We identify a large num-
ber of common and tissue-specific eQTLs. A large proportion of the discoveries are
replicated by the Meta-Tissue approach. The additional unique discoveries made by
our method are “near” discoveries for the Meta-Tissue method, as illustrated by the
highly skewed p-value distributions (see Figure 5). It indicates that HT-eQTL is able
to push the detection boundary in a favorable direction (i.e., more statistical power)
while preserving error control.
The proposed method relies on the marginal compatibility of the hierarchical
Bayesian model (1). In practice, if the joint distribution of the z-statistics deviates
from a multivariate Gaussian distribution, it may affect the model fitting. One way
to alleviate the problem is to transform the original z-statistics to make them jointly
Gaussian. A multivariate testing and transformation framework calls for more in-
vestigation. Another limitation of HT-eQTL in its current form is that it is limited
to 20-25 tissues. Extensions beyond this number will require additional prior infor-
mation about tissue groups, which may reduce the total number of configurations
considered in the model.
5 Conclusions
We present a scalable method for multi-tissue eQTL analysis. The method can ef-
fectively borrow strength across tissues to improve the power of eQTL detection in a
single tissue. It also has superior power to detect eQTL of different configurations.
The model parameters capture important biological insights into tissue similarity and
specificity. In particular, from the GTEx analysis we observe that most cis eQTLs are
present in either all tissues or a single tissue. The eQTLs identified by the proposed
method provide a valuable resource for subsequent analysis, and may facilitate the
discovery of genetic regulatory pathways underlying complex diseases.
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